- Home
- EVMN vs SCSC Comparison
EVMN vs SCSC Comparison
Compare EVMN & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | SCSC |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 879.2M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | EVMN | SCSC |
|---|---|---|
| Price | $22.03 | $42.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $43.88 | $43.00 |
| AVG Volume (30 Days) | ★ 300.6K | 237.3K |
| Earning Date | 06-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.42 |
| Revenue | N/A | ★ $3,846,260,000.00 |
| Revenue This Year | N/A | $2.60 |
| Revenue Next Year | N/A | $4.01 |
| P/E Ratio | ★ N/A | $17.48 |
| Revenue Growth | N/A | ★ 7.79 |
| 52 Week Low | $13.89 | $33.76 |
| 52 Week High | $33.20 | $46.64 |
Technical Indicators
Market Signals| Indicator | EVMN | SCSC |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 57.95 |
| Support Level | $21.39 | $42.71 |
| Resistance Level | $23.08 | $45.72 |
| Average True Range (ATR) | 1.56 | 1.84 |
| MACD | -0.21 | -0.08 |
| Stochastic Oscillator | 12.79 | 45.41 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.